Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytosorbents

1.10
+0.01000.92%
Volume:51.85K
Turnover:56.01K
Market Cap:68.75M
PE:-2.89
High:1.12
Open:1.12
Low:1.05
Close:1.09
Loading ...

Cytosorbents Corp expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
22 Mar

Cytosorbents Corp - Reaffirms Preliminary Financial Expectations for Q4 and FY 2024 - SEC Filing

THOMSON REUTERS
·
21 Mar

Cytosorbents Corp: Continues to Expect Regulatory Decisions on Drugsorb!"-Atr Marketing Applications in 2025

THOMSON REUTERS
·
21 Mar

CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit

PR Newswire
·
21 Mar

Cytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years ago

Simply Wall St.
·
10 Mar

BRIEF-Cytosorbents Corp Reaffirms Preliminary Financial Expectations For Q4 And FY 2024

Reuters
·
05 Mar

Cytosorbents Corp - Reaffirms Preliminary Financial Expectations for Q4 and FY 2024

THOMSON REUTERS
·
05 Mar

Cytosorbents Corp expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
05 Mar

CytoSorbents postpones earnings release to allow time for annual audit

TIPRANKS
·
04 Mar

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

GlobeNewswire
·
04 Mar

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

GlobeNewswire
·
26 Feb

Cytosorbents Is Maintained at Buy by D. Boral Capital

Dow Jones
·
25 Feb

CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants

GlobeNewswire
·
25 Feb

Cytosorbents Boosts Liquidity with Successful Rights Offering

TipRanks
·
14 Jan

Cytosorbents Is Maintained at Buy by D. Boral Capital

Dow Jones
·
13 Jan

CytoSorbents opens regional sales subsidiary in Dubai

TIPRANKS
·
06 Jan

CTSO: CytoSorbents Reports Preliminary 4th Quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations.

Zacks Small Cap Research
·
03 Jan

CytoSorbents reported strong Q4 results, says D. Boral Capital

TIPRANKS
·
03 Jan

Cytosorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

THOMSON REUTERS
·
03 Jan

Cytosorbents Initiates Rights Offering to Raise Capital

TIPRANKS
·
24 Dec 2024